Net Cash Provided by (Used in) Operating Activities |
1.48M |
USD |
+44.7% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-25K |
USD |
-56.3% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-1.99M |
USD |
+36.4% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
200M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
93.5M |
shares |
|
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-592K |
USD |
+73.7% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
28.3M |
USD |
-11.1% |
Q4 2023 |
FY 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Gross |
46.7M |
USD |
+9.61% |
Q4 2023 |
FY 2023 |
Payments to Acquire Property, Plant, and Equipment |
1.99M |
USD |
-36.4% |
Q1 2024 |
Q1 2024 |
Property, Plant and Equipment, Gross |
303M |
USD |
+2.7% |
Q3 2024 |
Q3 2024 |
Additional Paid in Capital |
115M |
USD |
+2.77% |
Q3 2024 |
Q3 2024 |
Depreciation, Depletion and Amortization |
4.58M |
USD |
-37% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
18.4M |
USD |
+70.8% |
Q4 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
826K |
USD |
-1.67% |
Q3 2024 |
Q3 2024 |